Abstract:To analyze the preliminary effects of the 125I radioactive seeds brachytherapy combined chemotherapy in the treatment of pediatric rhabdomyosarcoma which occurs in the head and neck. 17 pediatric patients with rhabdomyosarcoma in head and neck were treated in the Peking University School of stomatology from June 2013 to June 2015. Of the patients, the median age was 4 years old (range 1-16), the ratio of male:female was 12:5. The multimodality treatment of the 125I radioactive seeds brachytherapy combined chemotherapy was done after the pathological diagnosis was clear. The curative effect was observed by means of clinical indications, imaging examination, PET - CT, etc. This group of patients was followed up for 6 to 30 months. The clinical effect was evaluated until the 3rd half-life, without any additional local treatment. One patient developed intracranial metastases (12 months). Another patient of multiple rhabdomyosarcoma realized local control of implanted area, with intracranial and pulmonary metastasis. The local control was 100%, all patients survived during the follow-up period. The recent side effects were slight, mainly included pigment changes and minor pains of the mucosa, which could get spontaneous remission in half a year, and the long-term side effects will be under observation. 1. Compared with the conventional radiotherapy, 125I radioactive seeds brachytherapy realized the precise location of the target, and the dose reduction of surrounding nomal tissues and organs. It can also reduce the incidence of functional injury for the peripheral tissues and organs. The method is more suitable for the children with tumor in head and neck during the period of growth and development on the basis of safety and effectiveness. 2.For the pediatric rhabdomyosarcoma which occurs in head and neck, because of its complex anatomical structures, which is adjacent to the important blood vessels and nerves, complete resection surgery isn’t the first choice. Chemotherapy can decrease the stage of sarcoma and the rate of systemic metastasis in some degree, but radiotherapy plays a very important role as a necessary means to improve the local control rates of tumor. 3. In this paper, we had a discussion of the relationship among the curative effect of rhabdomyosarcoma children in the head and neck and the pathological type, stage, target and prescription dose. 4.The short-term outcome was good, the local control rate was high and there were no severe side effects. But there are lots of questions to be solved, including the prescription dose, the PTV, the long-term outcome (the influence of tooth jaw system, growth and physiological function, etc), which still need further research.

Long-term Result of 125 I Seed Brachytherapy for Pediatric Desmoid Tumor in the Head and Neck

Iodine-125 Interstitial Brachytherapy for Pediatric Desmoid-Type Fibromatosis of the Head and Neck: A Case Report

Stereotactic Brachytherapy with Iodine-125 Seeds Plus Temozolomide Induced Complete and Durable Remission in a Patient with Recurrent Primary Central Nervous System Lymphoma.

Target and dose design of 125I seed brachytherapy for treatment of pediatric borderline tumor in head neck region

The Clinical Investigation of the 125i Radioactive Seeds Brachytherapy Combined Chemotherapy in the Treatment of Pediatric Rhabdomyosarcoma in Head and Neck

[Clinical Application of 125I Radioactive Seeds Brachytherapy in the Treatment of the Pediatric Soft Tissue Sarcoma in Head and Neck].

Combined Chemotherapy And I-125-Particle Implantation For Treatment Of Children With Head And Neck Soft Tissue Sarcomas Improve The Short-Term Efficacy: Beijing Children'S Hospital Experience Over 2 Years

Initial Treatment for Surgery-Naïve Desmoid Tumors by High Intensity Focused Ultrasound

125I Interstitial Brachytherapy in Management of Pediatric Skull Base Tumors

Permanent interstitial 125 I seed implantation as a salvage therapy for pediatric recurrent or metastatic soft tissue sarcoma after multidisciplinary treatment

Radiotherapy in the Treatment of Primary or Recurrent Unresectable Desmoid Tumors of the Neck.

Mandibular Growth in Pediatric and Adolescent Survivors of Parotid Gland Cancer Treated with Interstitial Brachytherapy

Efficacy of Brachytherapy Concomitant with Chemotherapy with Docetaxel, Cisplatin, and 5-Fluorouracil in Unresectable Head and Neck Squamous Cell Carcinoma.

Efficacy and Safety of CT-Guided 125I Seed Implantation As a Salvage Treatment for Locally Recurrent Head and Neck Soft Tissue Sarcoma after Surgery and External Beam Radiotherapy: A 12-Year Study at a Single Institution

[Short- to Mid-Term Evaluation of CT-guided 125I Brachytherapy on Recurrent or Metastatic Head and Neck Cancers].

Five-year outcome of ultrasound-guided interstitial permanent 125 I seeds implantation for local head and neck recurrent tumors: a single center retrospective study.

Evaluation of radioactive 125I seed implantation for the treatment of refractory malignant tumours based on a CT-guided 3D template-assisted technique: efficacy and safety

Single Institution Experience of Split Course Radiotherapy in Patients with Desmoid Tumors

The efficacy and safety of <SUP>125</SUP>I brachytherapy combined with pre-operative transarterial chemoembolization in patients with locally advanced head and neck cancer

Postoperative Radiotherapy in Primary Resectable Desmoid Tumors of the Neck: a Case–control Study

Preliminary Results of (125)I Interstitial Brachytherapy for Locally Recurrent Parotid Gland Cancer in Previously Irradiated Patients.